Medimib – Bortezomib Injection
Description
BORTEZOMIB (MEDIMIB) INJECTION – TREATMENT OF NUMEROUS MYELOMA AND MANTLE-CELL LYMPHOMA
Medimib Injection is used to treat multiple myeloma and mantle-cell lymphoma. It demonstrates its effectiveness by preventing or slowing the growth of disease cells.
How Medimib Injection is Used.
A certified clinical professional administers Medimib Injection as an infusion. Your PCP will determine what portion is necessary and how frequently you must take it. This will depend on what you are being treated for and may alter from time to time. You should take it exactly as prescribed by your doctor. Misinterpreting it or consuming too much of it can have severe consequences.
Side Effects of This Injection
Weakness, queasiness, retching, and loss of craving are some of the medication’s most common side effects. Throughout the treatment, you may be instructed to drink a lot of liquids. Because medicine can cause sluggishness and discombobulation, you should not drive or work with heavy machinery. This medicine may reduce the number of platelets (red blood and white platelets) in your blood, increasing your susceptibility to illnesses.
If you have a liver, kidney, coronary ailment, or draining concern, consult your doctor before taking Injection. It is critical to consult a doctor if you experience symptoms such as cognitive impairment or difficulty reasoning.
